検索結果

ugs to treat a disease affecting less than 50,000 patients in Japan, with particularly high medical needs. This designation can be expected to shorten the period required for regulatory approval, resu...

to drive initiatives that contribute to the advancement of ophthalmic medical care and address the needs of healthcare professionals. [Contact details for inquiries follow] Medical Device Department,...

Product Development Policy | Research & Development | SENJU Pharmaceutica

bution of the diseases to visual impairment or blindness," "satisfaction of unmet medical needs*," and "possibility of commercialization." We have mainly developed ethical dru...

Research and Development System | Research & Development | SENJU Pharmaceutica

entional framework or stereotypes. Looking at the future and quickly developing safe drugs that are needed are our goals as well as our wishes. Message from Research and Development Division Executive...